Event-Driven Stocks

IMMUCOR INC

Healthcare · In Vitro & In Vivo Diagnostic Substances · GA · SEC filings ↗ · Compare ⊕

Signs3 good3 warning2 severedetails ↓

Financials

SEC XBRL · annual
 FY16FY15FY14FY13FY12FY11
Revenue$88.9M$95.6M$388.1M$347.8M$261.8M$74.9M
Operating income$5.1M$12.9M−$110.0M$36.7M−$4.6M−$6.5M
Net income−$8.4M−$60.7M−$182.3M−$39.1M−$49.6M−$6.4M
Total assets$1.71B$1.72B$1.82B$2.00B$1.95B$633.1M
Total liabilities$1.36B$1.34B$1.36B$1.36B$1.31B$64.3M
Equity$340.2M$383.7M$468.6M$644.7M$637.4M$568.9M
EPS (diluted)$1.26
Shares out.10010010010010070.5M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2016
Operating margin
5.7%
Net margin
−9.5%
Return on equity
−2.5%
Return on assets
−0.5%
Return on capital (ROCE)
0.3%
Liabilities / assets
79.8%
Debt / equity
4.01×
Book value / share
$3402230.00
Revenue growth (YoY)
−7.0%
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2016
Altman Z″ (distress)
-0.23distress
Accruals / assets
2.1%clean
Piotroski F-Score
4/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
45
/ 100
Profitability 40Growth 0Catalyst 33Earnings quality 100Financial strength 50

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

2 severe3 warning3 good
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Reported a net loss
  • Revenue declined year-over-year
  • High leverage (liabilities > 70% of assets)
  • Operating margin is positive
  • Positive operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.